Kutahya Medical Sciences University   Report issue

Academic/Hospital Phase 4
Founded: Kütahya Turkey (1992)

Organization Overview

First Clinical Trial
2019
NCT04601025
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Berceste Guler | Kutahya Health Sciences University | Kütahya Health Sciences University | Kütahya Health Sciences University Faculty of Dentistry | Kutahya Health Science University | Kütahya Health Science University | Kutahya Medical Sciences University

Active Ingredients

Drugs in Phase 4 Trials (1)

etodolac (lodine) (1 trial)

Drugs in Other Trials (3)

chickpea (1 trial)

gabapentin (neurontin) (2 trials)

pregabalin (lyrica) (2 trials)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4